BriaCell Therapeutics Corp. (BCTX) Other Accumulated Expenses (2021)
BriaCell Therapeutics (BCTX) posted Other Accumulated Expenses of $80967.0 for Q3 2021.
BriaCell Therapeutics Corp. (BCTX) Other Accumulated Expenses (2021) Analysis & Trends
BriaCell Therapeutics has reported Other Accumulated Expenses for 1 years, with the latest figure at $80967.0 in Q3 2021.
- Quarterly Other Accumulated Expenses changed N/A year-over-year to $80967.0 in Q3 2021, while the trailing twelve-month figure through Jul 2021 was $80967.0 (changed N/A YoY) and the FY2021 annual result came in at $80967.0, changed N/A from the prior year.
- Other Accumulated Expenses held at $80967.0 in Q3 2021 per BCTX's latest filing.
- Over five years, Other Accumulated Expenses peaked at $80967.0 in Q3 2021 and troughed at $80967.0 in Q3 2021.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2021 | 80,967.00 |